[go: up one dir, main page]

YU45098A - Kompozicije koje sadrže antifungicidno sredstvo i acetatni pufer - Google Patents

Kompozicije koje sadrže antifungicidno sredstvo i acetatni pufer

Info

Publication number
YU45098A
YU45098A YU45098A YU45098A YU45098A YU 45098 A YU45098 A YU 45098A YU 45098 A YU45098 A YU 45098A YU 45098 A YU45098 A YU 45098A YU 45098 A YU45098 A YU 45098A
Authority
YU
Yugoslavia
Prior art keywords
acetate buffer
compositions
antifungal agent
pharmaceutically acceptable
effective
Prior art date
Application number
YU45098A
Other languages
English (en)
Inventor
Maneesh J. Nerurkar
William A. Hunke
Michael J. Kaufman
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309400&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU45098(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9611006.9A external-priority patent/GB9611006D0/en
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of YU45098A publication Critical patent/YU45098A/sh
Publication of RS49566B publication Critical patent/RS49566B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Pronalazak je farmaceutska kompozicija za intravensku primenu kod pacijenta koja sadrži a) farmaceutski efikasnu količinu jedinjenja koje ima formulu i njegove farmaceutski prihvatljive soli; b) Farmaceutski prihvatljivu količinu inertnog punioca kao što je punioc efikasan da obrazuje liofilizirani kolač; i c) farmaceutski prihvatljivu količinu acetatnog pufera efikasnu da obezbedi pH od izmedju oko 4 i 7.
YUP-450/98A 1996-04-19 1998-10-15 Kompozicije koje sadrže antifungicidno sredstvo i acetatni pufer RS49566B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1563896P 1996-04-19 1996-04-19
GBGB9611006.9A GB9611006D0 (en) 1996-05-24 1996-05-24 Antifungal compositions

Publications (2)

Publication Number Publication Date
YU45098A true YU45098A (sh) 1999-07-28
RS49566B RS49566B (sr) 2007-04-10

Family

ID=26309400

Country Status (35)

Country Link
EP (1) EP0904098B1 (sh)
JP (1) JP3258672B2 (sh)
CN (1) CN1132624C (sh)
AR (1) AR006598A1 (sh)
AT (1) ATE241999T1 (sh)
AU (1) AU706250B2 (sh)
BG (1) BG64272B1 (sh)
BR (2) BRPI9708706C8 (sh)
CA (1) CA2251928C (sh)
CO (1) CO4940486A1 (sh)
CY (1) CY2374B1 (sh)
CZ (1) CZ289361B6 (sh)
DE (1) DE69722615T2 (sh)
DK (1) DK0904098T3 (sh)
DZ (1) DZ2205A1 (sh)
EA (1) EA001386B1 (sh)
EE (1) EE04265B1 (sh)
ES (1) ES2198569T3 (sh)
HR (1) HRP970201B1 (sh)
HU (1) HU228296B1 (sh)
ID (1) ID16643A (sh)
IL (1) IL126479A (sh)
IS (1) IS2159B (sh)
MY (1) MY126305A (sh)
NO (1) NO321954B1 (sh)
NZ (1) NZ332156A (sh)
PE (1) PE63998A1 (sh)
PL (1) PL187294B1 (sh)
PT (1) PT904098E (sh)
RS (1) RS49566B (sh)
SA (1) SA97180104B1 (sh)
SK (1) SK281969B6 (sh)
TR (1) TR199802102T2 (sh)
UA (1) UA55409C2 (sh)
WO (1) WO1997039763A1 (sh)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP970318B1 (en) 1996-06-14 2002-06-30 Merck & Co Inc A process for preparing certain aza cyclohexapeptides
RU2250763C2 (ru) * 1999-03-03 2005-04-27 Эли Лилли Энд Компани Фармацевтические препараты эхинокандина, содержащие мицелообразующие поверхностно-активные вещества
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
CN101516387B (zh) * 2006-07-26 2014-06-04 桑多斯股份公司 卡泊芬净制剂
KR101536781B1 (ko) * 2006-07-26 2015-07-14 산도즈 아게 카스포펀진 제형
EP2170362B1 (en) 2007-06-26 2015-11-04 Merck Sharp & Dohme Corp. Lyophilized anti-fungal composition
US8048853B2 (en) 2008-06-13 2011-11-01 Xellia Pharmaceuticals Aps Process for preparing pharmaceutical compound and intermediates thereof
US20100256074A1 (en) * 2008-06-25 2010-10-07 Chaim Eidelman Processes for preparing high purity aza cyclohexapeptides
WO2010108637A1 (en) * 2009-03-27 2010-09-30 Axellia Pharmaceuticals Aps Crystalline compound
CN102219832B (zh) * 2010-04-15 2013-08-21 上海天伟生物制药有限公司 一种氮杂环六肽或其盐的纯化方法
CN102367267B (zh) * 2010-11-10 2013-09-04 上海天伟生物制药有限公司 一种卡泊芬净的制备方法
CN102367268B (zh) * 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其用途
CN102367269B (zh) * 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其制备方法和用途
CN102614493B (zh) * 2011-01-31 2013-12-11 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂卡泊芬净的液体药用组合物
CN102488887B (zh) * 2011-01-31 2014-06-18 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂卡泊芬净的药用组合物及其制备方法和用途
CN102488888B (zh) * 2011-01-31 2014-07-30 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂的药用组合物及其制备方法和用途
SI2680873T1 (sl) 2011-03-03 2017-12-29 Cidara Therapeutics, Inc. Protiglivna sredstva in njihova uporaba
CN102166186A (zh) * 2011-04-18 2011-08-31 深圳市健元医药科技有限公司 一种更加稳定的氮杂环己肽类制剂
CN103386117B (zh) * 2011-09-26 2015-09-30 上海天伟生物制药有限公司 一种低杂质含量的卡泊芬净制剂及其制备方法和用途
CN103315969B (zh) * 2011-09-26 2016-05-18 上海天伟生物制药有限公司 一种低杂质含量的卡泊芬净制剂及其制备方法和用途
CN103212059A (zh) * 2012-01-18 2013-07-24 江苏恒瑞医药股份有限公司 含有抗真菌药物和乳酸盐缓冲液的组合物
PL3677252T3 (pl) * 2012-03-19 2024-01-08 Cidara Therapeutics, Inc. Schematy dawkowania dla związków z klasy echinokandyn
US9828411B2 (en) 2013-05-02 2017-11-28 Dsm Sinochem Pharmaceuticals Netherlands B.V. Method for isolating caspofungin
PL3058958T3 (pl) 2015-02-23 2019-02-28 Selectchemie Ag Kompozycja anidulafunginy
ES2955711T3 (es) 2016-03-16 2023-12-05 Cidara Therapeutics Inc Regímenes de dosificación para el tratamiento de infecciones fúngicas
CN111050798A (zh) 2017-07-12 2020-04-21 奇达拉治疗公司 用于治疗真菌感染的组合物和方法
CN109721641B (zh) * 2017-10-31 2021-08-03 鲁南制药集团股份有限公司 一种卡泊芬净的合成方法
CN113801202B (zh) * 2020-06-15 2024-11-05 杭州中美华东制药有限公司 一种醋酸卡泊芬净杂质g的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1234383A (en) * 1982-03-17 1983-09-22 Inter-Yeda Ltd. Interferon stabilised with polyvinyl-pyrrolidone
WO1989011297A1 (en) * 1988-05-27 1989-11-30 Centocor, Inc. Freeze-dried formulation for antibody products
US5939384A (en) * 1991-10-01 1999-08-17 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
IL109350A (en) * 1993-05-12 2001-01-28 Genentech Inc Stable liquid compositions of gamma interferon

Also Published As

Publication number Publication date
BR9708706B1 (pt) 2013-08-06
AU706250B2 (en) 1999-06-10
AR006598A1 (es) 1999-09-08
JP3258672B2 (ja) 2002-02-18
PT904098E (pt) 2003-09-30
RS49566B (sr) 2007-04-10
DE69722615T2 (de) 2004-04-29
MY126305A (en) 2006-09-29
HRP970201A2 (en) 1998-08-31
IS2159B (is) 2006-11-15
HUP9901586A3 (en) 2002-05-28
BRPI9708706C8 (pt) 2021-01-05
CA2251928C (en) 2003-06-17
DZ2205A1 (fr) 2002-12-03
WO1997039763A1 (en) 1997-10-30
DK0904098T3 (da) 2003-09-15
NO984860L (no) 1998-12-18
IL126479A0 (en) 1999-08-17
CN1132624C (zh) 2003-12-31
JPH11509555A (ja) 1999-08-24
BR9708706B8 (pt) 2019-03-06
CN1222082A (zh) 1999-07-07
EP0904098B1 (en) 2003-06-04
IL126479A (en) 2006-08-01
HRP970201B1 (en) 2002-06-30
NO984860D0 (no) 1998-10-16
NO321954B1 (no) 2006-07-31
ES2198569T3 (es) 2004-02-01
EA001386B1 (ru) 2001-02-26
EP0904098A1 (en) 1999-03-31
ID16643A (id) 1997-10-23
HU228296B1 (en) 2013-03-28
SK144898A3 (en) 1999-05-07
CA2251928A1 (en) 1997-10-30
SA97180104B1 (ar) 2006-02-08
UA55409C2 (uk) 2003-04-15
CZ334798A3 (cs) 1999-06-16
ATE241999T1 (de) 2003-06-15
CY2374B1 (en) 2004-06-04
SK281969B6 (sk) 2001-09-11
HUP9901586A2 (hu) 1999-08-30
BG102857A (en) 1999-09-30
PL187294B1 (pl) 2004-06-30
PL329442A1 (en) 1999-03-29
AU2731197A (en) 1997-11-12
NZ332156A (en) 2000-04-28
EE9800345A (et) 1999-04-15
EE04265B1 (et) 2004-04-15
DE69722615D1 (de) 2003-07-10
TR199802102T2 (xx) 1999-01-18
IS4858A (is) 1998-10-02
EA199800938A1 (ru) 1999-04-29
HK1020873A1 (en) 2000-05-26
PE63998A1 (es) 1998-10-30
BG64272B1 (bg) 2004-08-31
CO4940486A1 (es) 2000-07-24
BR9708706A (pt) 1999-08-03
CZ289361B6 (cs) 2002-01-16

Similar Documents

Publication Publication Date Title
YU45098A (sh) Kompozicije koje sadrže antifungicidno sredstvo i acetatni pufer
YU13695A (sh) Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije
TW427906B (en) Antifungal compositions
AU4264396A (en) Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
GEP19991870B (en) Alkyl Amine Derivatives of Substituted Quinoxaline 2,3-Diones as Glutamate Receptor Antagonists
KR970704435A (ko) 헤테로시클릭 화합물의 도파민-D 리간드로서의 용도(Use of Heterocyclic Compounds as Dopamines-D Ligands)
GEP19991649B (en) Composition of Derivatives of Cyclodextrins, Clathrating Composition Comprising the Same and Pharmaceutical Composition.
HU9603592D0 (en) Aryl-sulfonamido-hydroxamic acids of matrix-metalloproteinase-inhibiting activity
BE902897A (fr) Derives 3-aminopropoxyaryliques, leur preparation leur application comme medicaments et compositions pharmaceutiques les contenant
ES2158537T3 (es) Derivados de acidos ciclopropilalcanoicos.
DK0715623T3 (da) Blodpladeaggregationsinhibitorer
NO941276D0 (no) Lipofile, oligosakkaride antibiotikasaltpreparater
AU7694896A (en) Prompt-release pharmaceutical compositions
DK0659193T3 (da) Blodpladeaggregationsinhibitorer
PT804418E (pt) Inibidores da agregacao de plaquetas
KR950703941A (ko) 일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor)
GEP20032970B (en) Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
YU86792A (sh) Rastvor sparfloksacina, njegovo dobijanje i so sparfloksacina kao komponenta rastvora
GEP19991869B (en) Amino Acid Derivatives of Substituted Quinoxaline 2,3-Dione Derivatives as Glutamate Receptor Antagonists
HUP0001773A2 (hu) Szubsztituált tetrahidropiridinszármazékok, eljárás előállításukra, továbbá a vegyületeket tartalmazó gyógyászati készítmények
SE9403137D0 (sv) Derivatives of carbohydrates and compositions containing them
WO1999011651A3 (en) 3-descladinose 6-o-substituded erythromycin derivatives
KR940701407A (ko) 레닌 억제제로서의 하이드록시아지도 유도체 및 관련 화합물
MY116837A (en) Compositions for inhibiting platelet aggregation
YU227290A (sh) Farmaceutski preparati